Patent Eligibility as a Policy Lever to Regulate the Patenting of Personalized Medicine

被引：0

作者：

Holman, Christopher M. ^{[1
]}

机构：

[1] Univ Missouri Kansas City, Sch Law, Law, Kansas City, MO 64110 USA

来源：

PERSPECTIVES ON PATENTABLE SUBJECT MATTER | 2015年

关键词：

BILSKI;

D O I：

暂无

中图分类号：

D9 [法律]; DF [法律];

学科分类号：

0301 ;

摘要：

引用

页码：114 / 150

页数：37

共 47 条

[21] PERSONALIZED MEDICINE Health study set to decide data policy
Reardon, Sara
NATURE, 2015, 525 (7567) : 16 - 16
[22] R&D policy, agency costs and innovation in personalized medicine
Yin, Wesley
JOURNAL OF HEALTH ECONOMICS, 2009, 28 (05) : 950 - 962
[23] Personalized medicine policy challenges: measuring clinical utility at point of care
van Rooij, Tibor
Wilson, Donna M.
Marsh, Sharon
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (03) : 289 - 295
[24] The Best Offense Is a Good Defense: Patent Prosecution Strategies During Personalized Medicine Drug Development
Millonig, Robert C., Jr.
Gillentine, Marsha Rose
Hammond, Rebecca
BIOTECHNOLOGY LAW REPORT, 2015, 34 (01) : 39 - 43
[25] Owning health: medicine, ownership and Anglo-American patent cultures Introduction: plurality in patenting: medical technology and cultures of protection
Stark, James F.
BRITISH JOURNAL FOR THE HISTORY OF SCIENCE, 2016, 49 (04): : 533 - 540
[26] Translating personalized genomic medicine into clinical practice: evidence, values, and health policy
Bombard, Yvonne
GENOME, 2015, 58 (12) : 491 - 497
[27] Innovation in personalized medicine:: BiDil® as a case study for integrating clinical and policy developments
Issa, Amalia M.
Weiss, L. Todd
Tufail, Waqas
Phillips, Kathryn A.
Van Bebber, Stephanie L.
PERSONALIZED MEDICINE, 2006, 3 (04) : 421 - 427
[28] Personalized medicine and preventive health care: juxtaposing health policy and clinical practice
Gjodsbol, Iben Mundbjerg
Winkel, Bo Gregers
Bundgaard, Henning
CRITICAL PUBLIC HEALTH, 2021, 31 (03) : 327 - 337
[29] Tailored Treatment, Tailored Enforcement: Protecting Innovation in Personalized Medicine from a Patent-Protection Loophole
Whittle, James R.
GEORGE WASHINGTON LAW REVIEW, 2016, 84 (02) : 480 - 510
[30] Coverage Policy Development for Personalized Medicine: Private Payer Perspectives on Developing Policy for the 21-Gene Assay
Trosman, Julia R.
Van Bebber, Stephanie L.
Phillips, Kathryn A.
JOURNAL OF ONCOLOGY PRACTICE, 2010, 6 (05) : 238 - 242

← 1 2 3 4 5 →